Prospectus 5/29/2020 | NWBO Message Board Posts

Northwest Biotherapeutics Inc.

  NWBO website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email

NWBO   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  13986 of 13994  at  6/28/2020 4:24:50 PM  by


 In response to msg 13985 by  clsm
view thread

Re: Prospectus 5/29/2020

CAR-T therapies are of intense interest at the moment, but the total cost of a regimen is estimated by the Wall Street Journal between $463 and $968 thousand.  If the patient has an adverse reaction, like a cytokine storm, the price will necessarily go higher and CAR-T will rarely be the first therapy tried.  No doubt CAR-T has its charms, but it is yet another therapy with such a breath-taking price tag that cost will be a barrier to general adoption.  Like the numerous $1 million plus gene therapies, there will be young patients for whom such an expenditure can be justified, but GBM tends to strike an older population where cost will be more of an issue.
What works in the laboratory isn't necessarily going to be an economically sustainable therapy for the general population.  I wish that wasn't the case, but the reality is that cost increasingly matters.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 56
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Msg # Subject Author Recs Date Posted
13987 Re: Prospectus 5/29/2020 clsm 0 6/28/2020 5:24:36 PM
13988 Re: Prospectus 5/29/2020 longfellow95 0 7/1/2020 2:43:54 PM

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by